A systematic review of experimental and clinical studies of sildenafil citrate for intrauterine growth restriction and pre-term labour

References

• Abbott D, Comby P, Charuel C, Graepel P, Hanton G, Leblanc B, et al. Preclinical safety profile of sildenafil. International Journal of Impotence Research 2004; 16: 498–504
   PubMed Web of Science ®Google Scholar
• Agha A M, Taha R A. Sildenafil inhibits agonist-evoked rat uterine contractility: influence of guanylyl cyclase inhibition. European Journal of Pharmacology 2001; 428: 343–348
   PubMed Web of Science ®Google Scholar
• Al-Omari W R, Al-Shammaa H B, Al-Tikriti E M, Ahmed K W. Atosiban and nifedipine in acute tocolysis: a comparative study. European Journal of Obstetrics, Gynecology and Reproductive Biology 2006; 128: 129–134
   PubMed Web of Science ®Google Scholar
• Ballard S A, Gingell C J, Tang K, Turner L A, Price M E, Naylor A M. Effects of sildenafil on the relaxation of human corpus cavernosum tissue in vitro and on the activities of cyclic nucleotide phosphodiesterase isozymes. Journal of Urology 1998; 159: 2164–2171
   PubMed Web of Science ®Google Scholar
• Belik J. Sildenafil administration during pregnancy increases fetal rat weight gain. FASEB Journal 2005; 19: A1248
   Web of Science ®Google Scholar
• Brar H S, Rutherford S E. Classification of intrauterine growth retardation. Seminars in Perinatology 1988; 12: 2–10
   PubMed Web of Science ®Google Scholar
• Buhimschi C S, Garfield R E, Weiner C P, Buhimschi I A. The presence and function of phosphodiesterase type 5 in the rat myometrium. American Journal of Obstetrics and Gynecology 2004; 190: 268–274
   PubMed Web of Science ®Google Scholar
• Check J H, Graziano V, Lee G, Nazari A, Choe J K, Dietterich C. Neither sildenafil nor vaginal estradiol improves endometrial thickness in women with thin endometria after taking oral estradiol in graduating dosages. Clinical and Experimental Obstetrics and Gynecology 2004; 31: 99–102
   PubMedGoogle Scholar
• Corbin J D, Francis S H. Cyclic GMP phosphodiesterase-5: target of sildenafil. Journal of Biological Chemistry 1999; 274: 13729–13732
   PubMed Web of Science ®Google Scholar
• Durlach J, Guiet-Bara A, Pages N, Bac P, Bara M. Magnesium chloride or magnesium sulfate: a genuine question. Magnesium Research 2005; 18: 187–192
   PubMed Web of Science ®Google Scholar
• Ghofrani H A, Osterloh I H, Grimminger F. Sildenafil: from angina to erectile dysfunction to pulmonary hypertension and beyond. Nature Reviews Drug Discovery 2006; 5: 689–702
   PubMed Web of Science ®Google Scholar
• Gluckman P D, Pinal C S. Regulation of fetal growth by the somatotrophic axis. Journal of Nutrition 2003; 133: 1741–1746
   PubMed Web of Science ®Google Scholar
• Hernandez-Hernandez D, Vargas-Rivera M, Nava-Ocampo A A, Palma-Aguirre J, Sumano-Lopez H. Drug therapy and adverse drug reactions to terbutaline in obstetric patients: a prospective cohort study in hospitalized women. BMC Pregnancy and Childbirth 2002; 2: 3
   PubMedGoogle Scholar
• Hoekstra R E, Ferrara T B, Couser R J, Payne N R, Connett J E. Survival and long-term neurodevelopmental outcome of extremely premature infants born at 23 – 26 weeks' gestational age at a tertiary center. Pediatrics 2004; 113: e1–e6
   Web of Science ®Google Scholar
• Jackson G, Gillies H, Osterloh I. Past, present, and future: a 7-year update of Viagra (sildenafil citrate). International Journal of Clinical Practice 2005; 59: 680–691
   PubMed Web of Science ®Google Scholar
• Kane L B, Klings E S. Present and future treatment strategies for pulmonary arterial hypertension: focus on phosphodiesterase-5 inhibitors. Treatments in Respiratory Medicine 2006; 5: 271–282
   PubMedGoogle Scholar
• Khan R N, Hamoud H, Warren A, Wong L F, Arulkumaran S. Relaxant action of sildenafil citrate (Viagra) on human myometrium of pregnancy. American Journal of Obstetrics and Gynecology 2004; 191: 315–321
   PubMed Web of Science ®Google Scholar
• Lacassie H J, Germain A M, Valdes G, Fernandez M S, Allamand F, Lopez H. Management of Eisenmenger syndrome in pregnancy with sildenafil and L-arginine. Obstetrics and Gynecology 2004; 103: 1118–1120
   PubMed Web of Science ®Google Scholar
• Lang U, Baker R S, Braems G, Zygmunt M, Kunzel W, Clark K E. Uterine blood flow: a determinant of fetal growth. European Journal of Obstetrics, Gynecology, and Reproductive Biology 2003; 110: S55–S61
   Web of Science ®Google Scholar
• Mayor S. Pfizer will not apply for a licence for sildenafil for women. British Medical Journal 2004; 328: 542
   PubMedGoogle Scholar
• Molelekwa V, Akhter P, McKenna P, Bowen M, Walsh K. Eisenmenger's syndrome in a 27 week pregnancy: management with bosentan and sildenafil. Irish Medical Journal 2005; 98: 87–88
   PubMedGoogle Scholar
• Paulus W E, Strehler E, Zhang M, Jelinkova L, El-Danasouri I, Sterzik K. Benefits of vaginal sildenafil citrate in assisted reproduction therapy. Fertility and Sterility 2002; 77: 846–847
   PubMed Web of Science ®Google Scholar
• Raymajhi R, Pratap K. A comparative study between nifedipine and isoxsuprine in the suppression of preterm labour. Kathmandu University Medical Journal 2003; 1: 85–90
   PubMedGoogle Scholar
• Refuerzo J S, Sokol R J, Aranda J V, Hallak M, Hotra J W, Kruger M, et al. Sildenafil citrate and fetal outcome in pregnant rats. Fetal Diagnosis and Therapy 2006; 21: 259–263
   PubMed Web of Science ®Google Scholar
• Sanchez-Aparicio P, Villanueva-Garcia D, Mota-Rojas D, Alonso-Spilsbury M, Nava-Ocampo A, Arch-Tirado E, . Systemic effects of sildenafil citrate in gestation and perinatal period (in Spanish). Animal perinatology: clinical and experimental aspects (in Spanish). 1st edn, D Mota-Rojas, A Nava-Ocampo, D Villanueva-Garcia, M Alonso-Spilsbury, et al. B M Editores, SA de CV, México DF, México 2006; 59–70
   Google Scholar
• Sher G, Fisch J D. Vaginal sildenafil (Viagra): a preliminary report of a novel method to improve uterine artery blood flow and endometrial development in patients undergoing IVF. Human Reproduction 2000; 15: 806–809
   PubMed Web of Science ®Google Scholar
• Sher G, Fisch J D. Effect of vaginal sildenafil on the outcome of in vitro fertilization (IVF) after multiple IVF failures attributed to poor endometrial development. Fertility and Sterility 2002; 78: 1073–1076
   PubMed Web of Science ®Google Scholar
• Shields K M, Hrometz S L. Use of sildenafil for female sexual dysfunction. Annals of Pharmacotherapy 2006; 40: 931–934
   PubMed Web of Science ®Google Scholar
• Trujillo-Ortega M E, Mota-Rojas D, Hernandez-Gonzalez R, Velazquez-Armenta E Y, Nava-Ocampo A A, Ramirez-Necoechea R, et al. Obstetric and neonatal outcomes to recombinant porcine somatotropin administered in the last third of pregnancy to primiparous sows. Journal of Endocrinology 2006; 189: 575–582
   PubMed Web of Science ®Google Scholar
• van Veen A J, Pelinck M J, van Pampus M G, Erwich J J. Severe hypotension and fetal death due to tocolysis with nifedipine. British Journal of Obstetrics and Gynaecology 2005; 112: 509–510
   Google Scholar
• Wareing M, Myers J E, O'Hara M, Baker P N. Sildenafil citrate (Viagra) enhances vasodilatation in fetal growth restriction. Journal of Clinical Endocrinology and Metabolism 2005; 90: 2550–2555
   PubMed Web of Science ®Google Scholar
• Yanney M, Marlow N. Paediatric consequences of fetal growth restriction. Seminars in Fetal and Neonatal Medicine 2004; 9: 411–418
   PubMedGoogle Scholar
• Zoma W D, Baker R S, Friedman A, Clark K E. Sildenafil citrate (Viagra) increases uterine blood flow and potentiates estrogen-induced vasodilation (A814). Journal of the Society for Gynecologic Investigation 2001; 8: 286A
   Google Scholar